Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year

1993

Stage

Debt | Dead

Total Raised

$11.6M

Last Raised

$1M

About IntelliGene

Developer of a platform technology for molecular recognition and detection. The technology is based on ribozymes, nano-machines that facilitate a new mode of biomolecular recognition and signal amplification, and which can be inserted into cells using traditional vectors, in order to track a cell's metabolism while inside the cell and in vivo. The platform can recognize small molecules, proteins and nucleic acids, and the technology can also be applied to a standard DNA chip so that it can detect a wide range of biomolecules.

IntelliGene Headquarter Location

Am Veolamo Street P.O. Box 35241

Givat Shaul, 91351,

Israel

972 2 6540333

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing IntelliGene

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

IntelliGene is included in 1 Expert Collection, including Nanobiotechnology.

N

Nanobiotechnology

701 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.